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Abstracts / International Journal of Surgery 12 (2014) S13eS117S102Introduction: This paper aims to expand on Partin’s previous work by
analysing the impact of radiological stage, Gleason scoring and percentage
involvement seen in biopsy tissue, upon PSA scoring.
Methods: Data was collected retrospectively from a cohort of proven
prostate cancer patients in North Wales diagnosed between October 2012
& October 2013. From 236 patients, ninety-eight had undergone the full
staging investigations required for analysis.
Results: Results showed that PSA levels do not show predictable correla-
tion with tumour severity across each prognostic measure. Increase in PSA
from T0 to T2 tumours was not statistically signiﬁcant, and was weakly
signiﬁcant when comparing T2 to T3 tumours (p<0.1). No statistical sig-
niﬁcance was seen when comparing PSA results from 1st, 2nd, or total
Gleason scores. Although not statistically signiﬁcant, the trend shows
increasing PSA levels in patients with total Gleason scores from 6 to 8,
before a steep decline at 9& 10. Statistically signiﬁcant PSA rises were seen
with increasing tumour cell inﬁltration percentages when analysing both
average involvement across bilateral biopsy cores (p<0.05) and maximum
involvement in single cores (p<0.05).
Conclusions: In conclusion the percentage of tumour inﬁltration in any
volume of tissue appears to be the most signiﬁcant factor inﬂuencing PSA
levels.
0126: COOK RESONANCE METALLIC URETERIC STENT: CONTEMPORARY
CLINICAL SERIES ASSESSING FEASIBILITY, SAFETY AND EFFICACY
Dafydd Loughran *, Mohamed Abdulmajed, Rachel Jones,
Pallavoor Anandaram, Iqbal Shergill. Wrexham Maelor Hospital, Wales, UK.
Introduction: The Cook resonance metallic ureteric stent has been used as
an alternative method to treat upper urinary tract obstruction. In this
paper we assess the feasibility, safety and efﬁcacy of this procedure.
Methods: Clinical experience at our institution, between April 2010 and
October 2013 was critically assessed, in terms of patient demographics,
clinical indication, length of operative procedure, radiation exposure and
duration, as well as immediate and late complications.
Results: Overall, 39 Cook Resonance metallic ureteric stent insertions
(stent units) were placed in 17 patients over the 3 year study period
(Median age 62 years; range 45-90). Indications for stent insertion was
retroperitoneal ﬁbrosis (n¼17), malignancy (n¼11), and benign disease
(n¼11). Procedures were successful in all but one case, which required
antegrade approach, due to migrated stent. Median duration of surgery
was 28 mins (Range 12-90). Median radiation exposure was 764CGycm2
with an average X-Ray time of 3:22. Urosepsis occurred in 1 patient, and
late complication occurred in only one case, resulting in hydronephrosis
and was managed with nephrostomy insertion. Stent could not be toler-
ated in 2 stent units due to pain.
Conclusions: We have demonstrated that Cook resonance metallic stent
insertion is feasible, safe and efﬁcacious in cases of upper urinary tract
obstruction.
0130: HOW THE WORLDWIDE SHORTAGE OF BCG (IMMUCYST)
AFFECTED THE MANAGEMENT OF HIGH-RISK, NON-MUSCLE INVASIVE
BLADDER CANCER IN A DISTRICT GENERAL HOSPITAL
Matthew Hillen *, Alex Rawlinson, Amy Slater, Caroline Coull, Ian Mitchell.
Victoria Hospital, NHS Fife, Kirkcaldy, UK.
Introduction: This study investigated the recurrence rates of bladder
cancer in those receiving BCG (ImmuCyst) prior to the shortage, how
patients' management was affected during the shortage and the
recurrence rates when an alternative type of BCG (OncoTICE) was
introduced.
Methods: The study included 53 patients who received ImmuCyst be-
tween 2008-11, 40 patients whose management was affected by the
shortage in 2012 and 39 patients who are currently being treated with
OncoTICE. Data was collected retrospectively from patients' BCG treatment
regime records, pathology reports and clinic letters.
Results: 38/53 (72%) of those receiving ImmuCyst developed recurrence
from 2008-11. Of these 38 patients, 26 (68%) only received induction
therapy. During the shortage, 40 patients were receiving ImmuCyst and 3
were newly diagnosed. 5/40 (12.5%) developed recurrence and were put
on surveillance. 7/39 (18%) of those currently receiving OncoTICE have
developed recurrence.
Conclusions: This study has shown that the BCG shortage did not signif-
icantly affect the management of our patients and has actually led topatients being treated with a clinically observed better-tolerated BCG
therapy. It has been observed from the small numbers accrued so far that
OncoTICE is associated with a lower recurrence rate.
0145: COMPARISON OF OFF-CLAMP PARTIAL NEPHRECTOMY AND ON-
CLAMP PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-
ANALYSIS
Abhishek Trehan *. University of Oxford, Oxford, UK.
Introduction: To compare peri-operative and post-operative variables,
surgical complications, oncological outcomes and renal outcomes of off-
clamp partial nephrectomy and on-clamp partial nephrectomy.
Methods: A systematic search of the electronic databases, including
MEDLINE, Embase and The Cochrane Library. The pooled estimates of
tumour size, operative time, estimated blood loss, length of stay, overall
complications, transfusion rates, urinary leaks, positive surgical margins
and eGFR were calculated.
Results: Fourteen studies were included. There was no signiﬁcant differ-
ence between off-clamp partial nephrectomy and on-clamp partial ne-
phrectomy in terms of tumour size, operative time, estimated blood loss,
length of stay, overall complications, transfusion rates, urinary leaks,
positive surgical margins. Off-clamp partial nephrectomy was associated
with a signiﬁcantly lower reduction in eGFR than on-clamp partial ne-
phrectomy (standardised weighted mean difference (SWMD) ¼ 0.27, 95%
CI: 0.14e0.40, P < 0.0001).
Conclusions: Off-clamp partial nephrectomy may be associated with
improved long-term renal outcomes when compared to on-clamp partial
nephrectomy with no difference in peri-operative and post-operative
variables, surgical complications and oncological outcomes. However, the
meta-analysis was limited by the design of the underlying studies, and
hence further work is needed in order to deﬁnitively establish whether off-
clamp partial nephrectomy confers any advantage over on-clamp partial
nephrectomy.
0148: THE ROLE OF CULTURAL BACKGROUND ON ATTITUDES AND MAN-
AGEMENT OF LOWER URINARY TRACT SYMPTOMS: A COMPARATIVE
STUDY BETWEEN UGANDA AND THE UNITED KINGDOM
Alison Bing *,1, Aakash Pai 1, Blair Tweedie 1, Adam Jones 1, James N'Dow1,
Francis Banya 1. 1Kisiizi Hospital, Kabale, Uganda.
Introduction: Between Uganda and the UK: Establish the severity of lower
urinary tract symptoms (LUTS). Compare attitudes towards LUTS. Compare
management of LUTS.
Methods: Prospective data collection from 80 men aged 45-85 from a
Ugandan hospital and 80 men from two UK hospitals using the Interna-
tional Prostate Symptoms Score (IPSS) survey along with a socio-de-
mographic questionnaire. Data collected on age, medications, education
level, occupation and distance travelled to hospital. Exclusion criteria:
urological presenting complaint, catheter, urinary tract infection, neuro-
pathic bladder, prostatectomy.
Results: There was no difference in age or severity of LUTS
(p¼0.9741) between the two groups. No Ugandan subjects received
medical management for LUTS compared to 18% of UK participants.
87% of UK men with severe LUTS (IPSS 20-35) had a more severe
Quality of Life score of 4-6, which was signiﬁcantly higher than the
Ugandan group (60%) (p¼0.0476). In patients with worse LUTS, no
Ugandan men received medical management compared to 39% of UK
men.
Conclusions: Cultural background and expectations play an important
role in the management of LUTS, highlighting the importance of the pa-
tient's perception of symptoms. In addition, the contrasting access to
urological services between Uganda and the UK is demonstrated.
0211: IS THE DAYCASE TURBT A REALISTIC POSSIBILITY IN THE DISTRICT
HOSPITAL SETTING?
K.A. Bailey, T.E.M. Morrison *, M. Hilmy, S.C. Hagyard. York Hospital NHS
Trust, York, UK.
Introduction: 10,000 people are diagnosed with bladder cancer annually.
A TURBT (transurethral resection of bladder tumour) is the mainstay of
treatment. With greater demands on theatre time and an increasing drive
to theatre efﬁciency we wanted to evaluate the possibly of the day case
TURBT in our District Hospital. Nationally only 19.1% of TURBT's are per-
formed as a day case against a 40% target.
Abstracts / International Journal of Surgery 12 (2014) S13eS117 S103Methods: Retrospective data for 100 elective TURBT performed in a
non-day case setting between December 2012 and June 2013was collected.
Demographic data as well as preoperative tumour assessment, histology,
ﬁrst or recurrent surgery, total resected and length of stay was recorded.
Results: 43% of patients were discharged within 24 hours, increasing to
77% at 48 hours. Identiﬁable preoperative factors such as tumour size
affected hospital stay. With mean larger resections in those admitted
longer. (>48hrs 11.35g versus <48hrs 4.22g). First diagnosis, higher
tumour grade at histology and increasing age also affected admission.
Conclusions: There is a strong case fordaycaseTURBT. Prolongedstay is often
unavoidable, but predictable in the preoperative setting. As a result current
practice in our department has changed; those identiﬁed as suitable pre-
operatively undergo their TURBT as a day case. Re-audit is planned.
0240: HIGH-GRADE (G3/CIS) NON-MUSCLE INVASIVE BLADDER CANCER:
WHAT IS THE RISK OF BCG TREATMENT?
Karl Pang *, James Nicholas, Saiful Miah, Ranga Wickramarachchi,
Zahir Abbasi. The Department of Urology, Rotherham Hospital, Rotherham, UK.
Introduction: High-grade (G3/CIS) non-muscle invasive (NMI) bladder
cancer (BCa) has a signiﬁcant risk of progression to muscle-invasive BCa.
BCG or early cystectomy is the treatment option for these tumours. This
study aims to determine the risk of BCG bladder-preserving therapy.
Methods: A retrospective analysis was performed on patients who un-
derwent BCG or radical cystectomy for G3/CIS NMI BCa in our centre be-
tween Jan-1 2008 and Jan-1 2013. Our cancer database identiﬁed 319 new
BCa.
Results: Sixty-eight patients, median (IQR) age of 72 (65-82) years had G3/
CIS NMI BCa. Sixty-one received BCG, 7 underwent early cystectomy.
During a median follow-up of 26 (13-46.5) months, 24/68 (35.3%) patients
had recurrent disease: BCG group n¼21/61 (34.4%), 3 patients proceeded
to cystectomy; cystectomy group n¼3/7 (42.9%), p¼0.69. Two (3.3%) pa-
tients in the BCG group had a 2nd recurrence (one underwent cystectomy).
Ten deaths occurred: BCG group n¼8/57 (14%); cystectomy group n¼2/11
(18.2%) p¼0.66. The Disease-Speciﬁc-Mortality (DSM) was: BCG n¼7/57
(12.3%); cystectomy 1/11 (9.1%), p¼1.00.
Conclusions: Following solely BCG treatment for G3 NMI BCa, 49/57 (86%)
patients are alive, 40/57 (70.2%) are disease-free. The risk of recurrence
requiring cystectomy following initial BCG is 4/61 (6.6%). BCG offers
bladder-preserving treatment with a 70.2% disease-free survival.
0253: DOES 3-DIMENSIONAL (3D) VISION IN LAPAROSCOPIC PYELO-
PLASTY IMPROVE OPERATING TIME COMPARED TO 2D-LAPAROSCOPIC
PYELOPLASTY?
Michelle Christodoulidou *, Bachar Zelhof, Richard Napier-Hemy. Urology,
Department, Manchester Royal Inﬁrmary, CMFT, Manchester, UK.
Introduction: One of the difﬁculties in laparoscopic reconstructive sur-
gery is adaptation to a 2-Dimensional ﬂat view of the surgical ﬁeld and the
lack of depth perception which makes needle handling and suturing
challenging. This study aimed to determine whether the use of 3D-Visu-
alisation Systems in laparoscopic pyeloplasty improves operative time. We
also reviewed intra operative morbidity compared to 2D.
Methods: Data were collected retrospectively from all patients that un-
derwent a 3D-Laparoscopic Pyeloplasty and operative times and compli-
cations were compared to historical data from previous 2D-Pyeloplasties
performed in our department.
Results: In the last 10 months we have performed 8 3D-Pyeloplasties.
Mean operating time was 147 min (range 97-205 min) in 3D and 163 min
(109-233 min) in 2D-Pyeloplasties. The longest two 3D procedures were
performed by a supervised trainee. Excluding those two cases, 3D lapa-
roscopic pyeloplasty time was 28 min shorter compared to 2D. There were
no signiﬁcant intraoperative complications.
Conclusions: 3D laparoscopy improves the perception of depth increasing
the precision of suturing and reducing operating times. It can therefore
augment laparoscopic skills and improve the learning curve for laparo-
scopic surgery. 3D Vision has a place in Laparoscopy Pyeloplasty today and
a further evaluation of long-term operative outcomes is needed.
0272: ASSESSING AND IMPROVING THE QUALITY OF DOCUMENTATION
SURROUNDING URINARY CATHETER INSERTION
Fay Riley *, David Thurtle, Viktor Manolas, Konstantinos Charitopoulos.
West Middlesex University Hospital NHS Trust, Isleworth, London, UK.Introduction: Accurate documentation of urinary catheter insertion is an
important legal record and point of reference. We sought to audit the
quality of catheter documentation at West Middlesex University Hospital,
then improve documentation and patient care.
Methods: The notes of all adult inpatients with urinary catheters inserted
during their hospital stay were retrospectively reviewed. Catheter docu-
mentation, in either the medical or nursing notes, was compared against
10 EAUN guidelines1. A catheter pro-forma sticker was designed, publi-
cised and implemented and the audit repeated.
Results: 48 catheter insertions were included in the initial audit. Only
63.22% of the guidelines set out by EAUN were recorded accurately in
either set of notes. Identity of ‘catheteriser'(58%), indication(56%),
description of urine(8%) and residual volume(60%) were particularly
poorly documented. 32 Catheter insertions were included for re-audit,
when overall adherence to EAUN guidelines was 74.67%. The uptake of the
pro-forma sticker was low but when used, documentation was 96.3%
complete.
Conclusions: Documentation surrounding catheter insertion in our trust
is inadequate. Using a catheter insertion pro-forma sticker saves time and
improves quality of documentation. Further work is required to improve
the uptake of this documentation tool, which may be usefully imple-
mented in other hospital trusts.
0292: THE IMPACT OF AN OPERATIVE NOTE PROFORMA ON OPERATION
NOTE STANDARDS IN A DISTRICT GENERAL UROLOGY DEPARTMENT
Urpinder Singh Grewal *, Alexander Martin, Mark McGowan, Kunjan Patel,
Sadmeet Singh. Kings Mill Hospital, Mansﬁeld, UK.
Introduction: Our aim was to ascertain if operative notes within a district
general urology department adhered to Good Surgical Practice (Royal
College of Surgeons of England 2008) guidelines.
Method: We prospectively audited 100 urological operations performed
within the hospital and reviewed the operation notes against RCS guide-
lines. Following the initial audit, we designed and introduced a paper
based operative note proforma; a re-audit of 100 operations was then
undertaken.
Results: Initial results showed that compliance with certain ﬁelds was
very weak and that all areas could be improved. At re-audit all data criteria
standards were either maintained or improved. Prior to the proforma, time
and complications were only documented in 4% and 10% of operation notes
respectively. Following the proforma introduction this rose to 70% and 74%
respectively. The mean percentage data point inclusion rose from 67.2% to
91.8%.
Conclusions: This closed loop audit cycle presents evidence that the use of
an operative note proforma led to signiﬁcant improvements in operative
note standards within this urology department. A further re-audit must be
undertaken to ensure that these initial improvements are not simply
transient following the introduction of the proforma.
0319: INITIAL INVESTIGATION OF RENAL COLIC IN A DGH
Owain Fisher *, Kate Davies. Ysbyty Glan Clwyd, Rhyl, Denbighshire, UK.
Introduction: To assess timeliness of appropriate investigation of patients
presenting with symptoms of urolithiasis. As per BAUS guidelines. Review
of patients who were conﬁrmed as having urolithiasis and assess whether
acute admission could have been avoided.
Methods: All CTUs requested for suspected renal colic over a period of 6
months were reviewed. Patients who were previously known to have
urolithiasis were excluded. The notes were then reviewed to determine
diagnosis on discharge, intervention undertaken and if serum calcium and
urate measurements were undertaken.
Results: Total number of CTU’s requested for eligible patients 81. Total
number of new stone positive CTU’s 30 (37%). Number of patients diag-
nosed with renal colic 43. 13 patients had negative CTUs with evidence of
recent stone passage. Mean overall wait for CT 30.85 hrs. Mean weekday
wait 27.4 hours. Mean weekend wait 40.0hrs. 9 of 30 stone positive pa-
tients required intervention during the acute admission.
Conclusions: Admission on a weekend increases the likelihood of a
prolonged wait for imaging and prolonged hospital stay. The main reason
for admission was diagnostic uncertainty, whilst awaiting CTU. The
majority of patients conﬁrmed as having urolithiasis did not require
acute intervention. Expedited imaging from A&E may reduce acute
admissions.
